Condition
Diabetic Foot Ulcer Treatment
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07452354Not Yet Recruiting
AI-Based Diabetic Foot Recurrence Cohort
NCT07206862Not ApplicableNot Yet Recruiting
CHEMfoot: DEBRICHEM® in Chronic Diabetic Foot Wounds
NCT06197412Phase 4RecruitingPrimary
Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot Ulcer
Showing all 3 trials